Skip to content

Author

T. Al-Rousan

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 9771: Cardiovascular and Mortality Outcomes Associated with GLP-1 Receptor Agonists Among Adults with Prediabetes: A Propensity-Matched Real-World Cohort Study

Introduction: Prediabetes is a growing global health burden associated with elevated cardiovascular risk well before overt diabetes. Although glucagon-like peptide-1 receptor agonists (GLP-1RAs) confer cardiovascular benefit in type 2 diabetes and obesity, real-world data in overweight or obese adults with prediabet...

F. Qtaishat, H. Alhammouri, J. Yasin et al. · 0 citations
Nov 2026

Abstract 14489: GLP-1 Receptor Agonists vs. SGLT2 Inhibitors and Risk of Atrial Fibrillation in Patients with Obstructive Sleep Apnea and Obesity: A Propensity-Matched Analysis

Introduction: Obstructive sleep apnea (OSA) and obesity are established risk factors for atrial fibrillation (AF) through shared mechanisms including chronic intermittent hypoxia, sympathetic activation, and atrial remodeling. GLP-1 receptor agonists (GLP-1 RA) and SGLT2 inhibitors (SGLT2i) are increasingly used in...

Zaid Al-Kofahi, H. Alhammouri, F. Qtaishat et al. · 0 citations
Review Open access Oct 2026

Exploring Barriers and Facilitators to Maintaining Cardiovascular Health Among Syrian Refugees: A Qualitative Study in a Refugee Camp Setting.

AIM To explore the barriers and facilitators to maintaining cardiovascular health among Syrian refugees living in the Zaatari camp. DESIGN A qualitative study guided by the Social Determinants of Health framework. METHODS Focus group discussions were conducted with 13 Syrian refugees. Twelve themes were identified,...

Abeer Alharthi, Hind Alzahrani, Rawnaq Behnam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.